These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12640213)

  • 1. The effect of risperidone treatment on superoxide dismutase in schizophrenia.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
    J Clin Psychopharmacol; 2003 Apr; 23(2):128-31. PubMed ID: 12640213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.
    Zhang XY; Zhou DF; Shen YC; Zhang PY; Zhang WF; Liang J; Chen DC; Xiu MH; Kosten TA; Kosten TR
    Neuropharmacology; 2012 Apr; 62(5-6):1928-34. PubMed ID: 22227558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.
    Zhang XY; Zhou DF; Qi LY; Chen S; Cao LY; Chen DC; Xiu MH; Wang F; Wu GY; Lu L; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2009 May; 204(1):177-84. PubMed ID: 19139851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.
    Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F
    Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia.
    Zhang XY; Zhou DF; Yuan CL; Zhang PY; Wu GY; Shen YC
    Psychiatry Res; 2002 Apr; 109(3):297-302. PubMed ID: 11959366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Zhang XY; Zhou DF; Cao LY; Chen DC; Zhu FY; Wu GY
    Schizophr Res; 2003 Aug; 62(3):245-50. PubMed ID: 12837521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Wu GY
    Psychopharmacology (Berl); 2006 Sep; 188(1):12-7. PubMed ID: 16906395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
    Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
    Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia.
    Atmaca M; Tezcan E; Kuloglu M; Ustundag B; Kirtas O
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):652-6. PubMed ID: 16401239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
    J Clin Psychiatry; 2004 Jul; 65(7):940-7. PubMed ID: 15291683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
    Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
    Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
    Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia.
    Lane HY; Chang YC; Cheng YC; Liu GC; Lin XR; Chang WH
    J Clin Psychiatry; 2003 Mar; 64(3):316-20. PubMed ID: 12716274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.
    Konarzewska B; Waszkiewicz N; Galińska B; Szulc A
    Neuro Endocrinol Lett; 2013; 34(4):322-8. PubMed ID: 23803867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
    J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
    [No Abstract]   [Full Text] [Related]  

  • 20. Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort Study.
    Xiu M; Song X; Yang H; Huang X; Wu F; Zhang X
    Curr Neuropharmacol; 2023; 21(10):2151-2158. PubMed ID: 37132112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.